Cadence Capital Management LLC bought a new position in Express Scripts Holding Company (NASDAQ:ESRX) during the third quarter, according to its most recent 13F filing with the SEC. The fund bought 24,472 shares of the company’s stock, valued at approximately $1,550,000.

Several other institutional investors have also bought and sold shares of ESRX. Burt Wealth Advisors increased its holdings in shares of Express Scripts by 11.4% in the 2nd quarter. Burt Wealth Advisors now owns 1,696 shares of the company’s stock worth $108,000 after buying an additional 174 shares during the last quarter. CKW Financial Group grew its holdings in Express Scripts by 20.0% during the 2nd quarter. CKW Financial Group now owns 1,800 shares of the company’s stock valued at $115,000 after purchasing an additional 300 shares during the last quarter. IHT Wealth Management LLC grew its holdings in Express Scripts by 8.1% during the 1st quarter. IHT Wealth Management LLC now owns 1,944 shares of the company’s stock valued at $128,000 after purchasing an additional 145 shares during the last quarter. First Personal Financial Services grew its holdings in Express Scripts by 199.1% during the 2nd quarter. First Personal Financial Services now owns 2,103 shares of the company’s stock valued at $134,000 after purchasing an additional 1,400 shares during the last quarter. Finally, FNY Partners Fund LP bought a new position in Express Scripts during the 1st quarter valued at about $138,000. Hedge funds and other institutional investors own 88.44% of the company’s stock.

In other Express Scripts news, VP Phyllis S. Anderson sold 578 shares of the business’s stock in a transaction dated Friday, September 8th. The shares were sold at an average price of $63.13, for a total value of $36,489.14. Following the completion of the sale, the vice president now directly owns 10,530 shares of the company’s stock, valued at approximately $664,758.90. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, CEO Timothy C. Wentworth acquired 8,000 shares of the stock in a transaction on Tuesday, October 31st. The stock was bought at an average cost of $61.13 per share, with a total value of $489,040.00. Following the completion of the transaction, the chief executive officer now owns 98,628 shares in the company, valued at $6,029,129.64. The disclosure for this purchase can be found here. Over the last three months, insiders sold 5,121 shares of company stock valued at $325,920. 0.68% of the stock is owned by corporate insiders.

Several brokerages recently commented on ESRX. Jefferies Group reiterated a “buy” rating on shares of Express Scripts in a report on Thursday, October 26th. Royal Bank Of Canada set a $66.00 price target on shares of Express Scripts and gave the company a “hold” rating in a report on Wednesday, October 25th. Robert W. Baird upped their price target on shares of Express Scripts from $57.00 to $59.00 and gave the company a “neutral” rating in a report on Wednesday, October 25th. Mizuho set a $67.00 price target on shares of Express Scripts and gave the company a “hold” rating in a report on Tuesday, October 24th. Finally, Zacks Investment Research downgraded shares of Express Scripts from a “buy” rating to a “sell” rating in a report on Tuesday, October 24th. Six equities research analysts have rated the stock with a sell rating, ten have issued a hold rating, six have assigned a buy rating and one has given a strong buy rating to the company’s stock. The company presently has an average rating of “Hold” and a consensus target price of $70.34.

Shares of Express Scripts Holding Company (NASDAQ ESRX) opened at $64.41 on Friday. The stock has a market cap of $36,916.19, a PE ratio of 9.53, a price-to-earnings-growth ratio of 0.96 and a beta of 0.88. The company has a debt-to-equity ratio of 0.86, a current ratio of 0.73 and a quick ratio of 0.61. Express Scripts Holding Company has a 52-week low of $55.80 and a 52-week high of $77.25.

Express Scripts (NASDAQ:ESRX) last released its quarterly earnings data on Tuesday, October 24th. The company reported $1.90 earnings per share (EPS) for the quarter, meeting the consensus estimate of $1.90. The company had revenue of $24.68 billion during the quarter, compared to analysts’ expectations of $25.68 billion. Express Scripts had a net margin of 3.64% and a return on equity of 25.46%. The firm’s quarterly revenue was down 2.9% on a year-over-year basis. During the same period in the previous year, the company earned $1.74 EPS. equities research analysts anticipate that Express Scripts Holding Company will post 7.01 earnings per share for the current year.

WARNING: This article was originally reported by Daily Political and is the property of of Daily Political. If you are viewing this article on another site, it was copied illegally and republished in violation of United States & international copyright and trademark laws. The legal version of this article can be read at https://www.dailypolitical.com/2017/12/02/cadence-capital-management-llc-takes-1-55-million-position-in-express-scripts-holding-company-esrx.html.

About Express Scripts

Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).

Institutional Ownership by Quarter for Express Scripts (NASDAQ:ESRX)

Receive News & Ratings for Express Scripts Holding Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts Holding Company and related companies with MarketBeat.com's FREE daily email newsletter.